<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02153749</url>
  </required_header>
  <id_info>
    <org_study_id>1210010970</org_study_id>
    <secondary_id>P50DA009241</secondary_id>
    <nct_id>NCT02153749</nct_id>
  </id_info>
  <brief_title>Effects of Brief Training on Craving Regulation</brief_title>
  <official_title>Regulation of Craving: Brief Neurocognitive Training and Neural Mechanisms</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yale University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Yale University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators propose that brief training in regulation of craving may increase the
      efficacy of smoking cessation, but that training in cognitive vs. mindfulness-based
      strategies may operate via different psychological and neural mechanisms.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators propose to test the efficacy of such training by randomizing 126 cigarette
      smokers to the following conditions: 1) brief training in cognitive regulation of craving 2)
      mindfulness-based training, and 3) control or no training. Training will be delivered in 6x1
      hour computerized sessions over four weeks. Control subjects simply fill out assessments
      during their visits. Participants who were randomized into the cognitive or mindfulness
      training complete Regulation of Craving (ROC) training sessions of approximately 60-90
      minutes. If randomized into the cognitive regulation training, subjects will be trained to
      use a cognitive strategy that instructs them to think of all the negative outcomes associated
      with continued cigarette smoking. If randomized into the MBT-based regulation training,
      subjects will be trained to use a mindfulness strategy that instructs them to notice and
      accept their feelings of craving without judgment or intent to act upon them. After all
      training sessions are completed, there is a 4 week and 12 week follow-up. The investigators
      will evaluate the effects of training on craving and regulation of craving measured by
      self-report and functional magnetic resonance imaging during the Regulation of Craving(ROC)
      task administered pre- and post- treatment, as well as smoking.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">August 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Self-report Craving level</measure>
    <time_frame>Baseline to 4 weeks</time_frame>
    <description>ROC task performance, as change from pre- to post- training in (1) craving (operationalized as self-reported craving on craving trials). (2) strategy-specific regulation (operationalized as scores on regulation trials using the trained strategy: LATER/control trials for CBT-based training, ACCEPT/mindfulness trials for MBT-based training). (3) strategy-non-specific regulation (scores on regulation - using the non-trained strategy: LATER trials for MBT-based training, ACCEPT trials for CBT-based training).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>% change in craving and control related neural activity measured via fMRI</measure>
    <time_frame>Baseline to 4 weeks</time_frame>
    <description>The neural activity component will be calculated as change from pre-to post- training during fMRI ROC task, including (1) craving- related activity (operationalized as neural reactivity in &quot;craving regions&quot; including Ventral Striatum, ventral medial Pre-Frontal Cortex); (2) neural substrates of control during regulation of craving (operationalized as neural activity in &quot;control regions&quot; including dorsal lateral and ventral lateral prefrontal cortex).</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Smoking</measure>
    <time_frame>baseline to 4 weeks</time_frame>
    <description>Measurement of reduction in cigarette smoking, measured by self report/cotinine/CO2, and FTND smoking severity</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Cognitive Control &amp; Affective Reactivity Behavioral Assessments</measure>
    <time_frame>baseline to 4 weeks</time_frame>
    <description>Detection of generalized effects of the training on affective reactivity and cognitive control, including: (1) Distress Tolerance, (2) CANTAB neuropsychological assessments, and (3) Drug Risk Response Task (DRRT) to measure regulation skills acquisition.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in general neural activity measured via fMRI</measure>
    <time_frame>Baseline to 4 weeks</time_frame>
    <description>Determination if the effects of training generalize to other measures of cognitive control/distress tolerance, using fMRI task neural activity.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Gender</measure>
    <time_frame>4 weeks</time_frame>
    <description>Whether gender moderates any of the findings</description>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">126</enrollment>
  <condition>Nicotine Addiction</condition>
  <arm_group>
    <arm_group_label>Cognitive Regulation of Craving</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Training in craving regulation component of Cognitive Behavioral Therapy(CBT) for addictions.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mindfulness-Based Regulation of Craving</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Training in craving regulation component of Mindfulness Based Therapy(MBT) for addiction.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No training control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No training sessions will be provided in this arm.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Regulation of Craving</intervention_name>
    <description>Regulation strategy practice: Participants will be trained to use a CBT-based cognitive regulation strategy. They will be asked to think of their individualized negative consequences for and thing of them when they see the instruction &quot;LATER&quot; during the task. Participants will practice using this strategy for multiple cigarette stimuli. High-Risk Situation Practice: Participants will identify 10 situations in which they usually smoke, or are likely to smoke in the next 48 hours. For each situation, they will be asked to practice using the strategy and to plan to use this strategy to regulate craving in daily life.</description>
    <arm_group_label>Cognitive Regulation of Craving</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Mindfulness-Based Regulation of Craving</intervention_name>
    <description>Each training session in this condition will be identical to the CBT-based training session described, with the exception of the strategy being trained. Specifically, participants will be trained in using the MBT-based strategy (&quot;notice craving and accept the feeling without judgment or reaction&quot;). To do so, they will be asked to generate their own non- reactive responses to craving (e.g., &quot;I can just sit here and notice this. I can ask myself, 'can I be ok with this feeling?'&quot;) Participants will then be instructed to think of those accepting and non-reactive responses when they see the instruction &quot;ACCEPT&quot; during the task. All other components will be identical.</description>
    <arm_group_label>Mindfulness-Based Regulation of Craving</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Between the ages of 18 and 60

          2. Smoking 10 or more cigarettes per day,

          3. Score &gt;4 on the Fagerstrom Test For Nicotine Dependence (FTND)

          4. Treatment seeking (motivated to quit or reduce smoking; &gt;6 on a 10 point likert scale)

          5. Fluent English speaker

          6. Can commit to the full length of the protocol (~8 weeks) and

          7. Are willing to be randomized to treatment condition.

        Exclusion Criteria:

          1. Current or past comorbid Axis I disorders (assessed via the Mini Psychiatric Interview
             Diagnosis; MINI)

          2. Current use of any psychoactive medications that have not been at a stable dose for
             the past 6 months, are used as mood stabilizers, or are used as smoking cessation
             treatments (e.g. varenicline).

          3. Serious or unstable medical condition within past 6 months

          4. Use of an investigational drug currently or within past 30 days

          5. Use of psychoactive medications or those that affect blood flow

          6. Other conditions contra-indicated for MRI (e.g., claustrophobia, presence of
             ferromagnetic metal in the body, prior head trauma with loss of consciousness, color
             blindness, hypertension, pregnancy).

          7. For females only: pregnancy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hedy Kober, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale School of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Matthew G Schafer, B.A.</last_name>
    <phone>203-737-4714</phone>
    <email>matthew.schafer@yale.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shosuke Suzuki, B.S.</last_name>
    <phone>203-737-4714</phone>
    <email>shosuke.suzuki@yale.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Clinical &amp; Affective Neuroscience Lab</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matthew Schafer, B.A.</last_name>
      <phone>203-737-4714</phone>
      <email>matthew.schafer@yale.edu</email>
    </contact>
    <contact_backup>
      <last_name>Shosuke Suzuki, B.S.</last_name>
      <phone>2037374714</phone>
      <email>shosuke.suzuki@yale.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Hedy Kober, Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Witkiewitz K, Bowen S, Douglas H, Hsu SH. Mindfulness-based relapse prevention for substance craving. Addict Behav. 2013 Feb;38(2):1563-71. doi: 10.1016/j.addbeh.2012.04.001. Epub 2012 Apr 6. Erratum in: Addict Behav. 2018 Mar 21;:.</citation>
    <PMID>22534451</PMID>
  </reference>
  <reference>
    <citation>Ferguson SG, Shiffman S. The relevance and treatment of cue-induced cravings in tobacco dependence. J Subst Abuse Treat. 2009 Apr;36(3):235-43. doi: 10.1016/j.jsat.2008.06.005. Epub 2008 Aug 20. Review.</citation>
    <PMID>18715743</PMID>
  </reference>
  <reference>
    <citation>Elwafi HM, Witkiewitz K, Mallik S, Thornhill TA 4th, Brewer JA. Mindfulness training for smoking cessation: moderation of the relationship between craving and cigarette use. Drug Alcohol Depend. 2013 Jun 1;130(1-3):222-9. doi: 10.1016/j.drugalcdep.2012.11.015. Epub 2012 Dec 21.</citation>
    <PMID>23265088</PMID>
  </reference>
  <reference>
    <citation>Carroll KM. Therapy Manuals for Drug Addiction. A Cognitive-Behavioral Approach: Treating Cocaine ï¿¼Addiction. In: Abuse NIoD, ed. Bethesda, MD: National Institute of Drug Abuse; 1998.</citation>
  </reference>
  <reference>
    <citation>Brewer JA, Mallik S, Babuscio TA, Nich C, Johnson HE, Deleone CM, Minnix-Cotton CA, Byrne SA, Kober H, Weinstein AJ, Carroll KM, Rounsaville BJ. Mindfulness training for smoking cessation: results from a randomized controlled trial. Drug Alcohol Depend. 2011 Dec 1;119(1-2):72-80. doi: 10.1016/j.drugalcdep.2011.05.027. Epub 2011 Jul 1.</citation>
    <PMID>21723049</PMID>
  </reference>
  <reference>
    <citation>Kober H, Kross EF, Mischel W, Hart CL, Ochsner KN. Regulation of craving by cognitive strategies in cigarette smokers. Drug Alcohol Depend. 2010 Jan 1;106(1):52-5. doi: 10.1016/j.drugalcdep.2009.07.017. Epub 2009 Sep 11.</citation>
    <PMID>19748191</PMID>
  </reference>
  <reference>
    <citation>Kober H, Mende-Siedlecki P, Kross EF, Weber J, Mischel W, Hart CL, Ochsner KN. Prefrontal-striatal pathway underlies cognitive regulation of craving. Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14811-6. doi: 10.1073/pnas.1007779107. Epub 2010 Aug 2.</citation>
    <PMID>20679212</PMID>
  </reference>
  <reference>
    <citation>Westbrook C, Creswell JD, Tabibnia G, Julson E, Kober H, Tindle HA. Mindful attention reduces neural and self-reported cue-induced craving in smokers. Soc Cogn Affect Neurosci. 2013 Jan;8(1):73-84. doi: 10.1093/scan/nsr076. Epub 2011 Nov 22.</citation>
    <PMID>22114078</PMID>
  </reference>
  <reference>
    <citation>Tang YY, Tang R, Posner MI. Brief meditation training induces smoking reduction. Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13971-5. doi: 10.1073/pnas.1311887110. Epub 2013 Aug 5.</citation>
    <PMID>23918376</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 23, 2014</study_first_submitted>
  <study_first_submitted_qc>May 30, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2014</study_first_posted>
  <last_update_submitted>January 5, 2018</last_update_submitted>
  <last_update_submitted_qc>January 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

